
9
pulsating blood ow of subject is required. For a subject with weak
pulse due to shock, low ambient/body temperature, major bleeding,
or use of vascular contracting drug, the SpO2 waveform (PLETH)
will decrease. In this case, the measurement will be more sensitive
to interference.
2. For those with a substantial amount of staining dilution drug (such
as methylene blue, indigo green and acid indigo blue), or carbon
monoxide hemoglobin (COHb), or methionine (Me+Hb) or thiosali-
cylic hemoglobin, and some with icterus problem, the SpO2 deter-
mination by this monitor may be inaccurate.
3. The drugs like dopamine, procaine, prilocaine, lidocaine and buta-
caine may also be a major factor blamed for serious error of SpO2
measure.
4. As the SpO2 value serves as a reference value for judgement of
anemic anoxia and toxic anoxia, some patients with serious anemia
may also report good SpO2 measurement.
4 Technical Specifications
1. Display Format: LCD Display; SpO2 Measuring Range: 0% ~ 100%;
Pulse Rate Measuring Range: 30 bpm ~ 250 bpm; Pulse Wave Dis-
play: columniation display and the waveform display.
2. Power Requirements: 2×1.5 V AAA alkaline battery (or using the re-
chargeable battery instead),adaptable range: 2.6 V - 3.6 V.
3. Power Consumption: Smaller than 30 mA.
4. Resolution: 1% for SpO2 and 1 bpm for Pulse Rate.
5. Measurement Accuracy: ±2% in stage of 70% ~ 100% SpO2, and
meaningless when stage being smaller than 70%. ±2 bpm during
the pulse rate range of 30 bpm ~ 99 bpm and ±2% during the pulse
rate range of 100 bpm ~ 250 bpm .
6. Measurement Performance in Weak Filling Condition: SpO2 and
pulse rate can be shown correctly when pulse-lling ratio is 0.4%.
SpO2 error is ±4%, pulse rate error is ± 2 bpm during the pulse rate
range of 30 bpm ~ 99 bpm and ±2% during the pulse rate range of
100 bpm ~ 250 bpm .
ENGLISH